Cancer Screening and Detection in Patients with End-Stage Renal Disease

National Center for Health Statistics. Deaths from 72 selected causes by age: United States, 1992. Monthly Vital Statistics Report.Volume 43. No.6(S), 1995.

United States Renal Data System. 1997 Annual Data Report. Chapter 6: Causes of death. Available on the world wide web at http://www.med.umich.edu/usrds.

Matas A.J. , Simmons R.L. , Kjellstrand C.M. , Buselmeier T.J. , Najarian J.S. . Increased incidence of malignancy during chronic renal failure. Lancet 1975; 2: 883–6.

Miach P.J. , Dawborn J.K. , Xipell J. . Neoplasia in patients with chronic renal failure on long-term dialysis. Clin Nephrol 1976; 5: 101–4.

Sutherland G.A. , Glass J. , Gabriel R. . Increased incidence of malignancy in chronic renal failure. Nephron 1977; 18: 182–4.

Herr H.W. , Engen D.E. , Hostetler J. . Malignancy in uremia: dialysis versus transplantation. J Urol 1979; 121: 584–6.

Lindner A. , Farewell V.T. , Sherrard D.J. . High incidence of neoplasia in uremic patients receiving long-term dialysis. Nephron 1981; 27: 292–6.

Port F.K. , Ragheb N.E. , Schwartz A.G. , Hawthorne V.M. . Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 1989; 14: 119–23.

Inamoto H. , Ozaki R. , Matsuzaki T. , Wakui M. , Saruta T. , Osawa A. . Incidence and mortality pattern of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 1991; 59: 611–7.

Slifkin R.F. , Goldberg J. , Neff M.S. , Baez A. , Mattoo N. , Gupta S. . Malignancy in end-stage renal disease. Trans Am Soc Artif Intern Organs 1977; 23: 34–9.

Kinlen L.J. , Eastwood J.B. , Kerr D.N.S. , Moorhead J.F. , Oliver D.O. , Robinson B.H.B. , deWardener H.E. , Wing A.J. . Cancer in patients receiving dialysis. BMJ 1980; 280: 1401–3.

Kantor A.F. , Hoover R.N. , Kinlen L.J. , McMullan M.R. , Fraumeni J.F. . Cancer in patients receiving long-term dialysis treatment. Am J Epidemiol 1987; 126: 370–6.

Curtis J.R. . Cancer and patients with end-stage renal failure. BMJ 1982; 284: 69–70.

Robles N.R. , Calero R. , Rengel M. , Valderrabano F. . Hemodialysis and cancer. Nephron 1990; 54: 271–2.

Penn I. , Starzl T.E. . Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972; 14: 407–17.

Hoover R. , Fraumeni J.F. . Risk of cancer in renal-transplant recipients. Lancet 1973; 2: 55–7.

Sheil A.G.R. , Flavel S. , Disney A.P.S. , Mathew T.H. . Cancer development in patients progressing to dialysis and renal transplantation. Transplantation Proc 1985; 17: 1685–8.

Penn I. , Brunson M.E. . Cancers after cyclosporine therapy. Transplantation Proc 1988; 20: S885–S92.

Barrett W.L. , First M.R. , Aron B.S. , Penn I. . Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72: 2186–9.

Bengtsson U. , Angervall L. , Ekman H. , Lehmann L. . Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 1968; 2: 145–50.

Dunnill M.S. , Millard P.R. , Oliver D. . Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol 1977; 30: 868–77.

Matson M.A. , Cohen E.P. . Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine 1990; 69: 217–26.

Chandhoke P.S. , Torrence R.J. , Clayman R.V. , Rothstein M. . Acquired cystic disease of the kidney: a management dilemma. J Urol 1992; 147: 969–74.

Pope J.C. , Koch M.O. , Bluth R.F. . Renal cell carcinoma in patients with end-stage renal disease: a comparison of clinical significance in patients receiving hemodialysis and those with renal transplants. Urology 1994; 44: 497–501.

Mausner JS , Kramer S. . Epidemiology: an introductory text. Philadelphia, PA: W.B. Saunders Company, 1985.

American Cancer Society. Guidelines for the cancer related checkup. Available on the world wide web at http://www.cancer.org.

Chertow G.M. , Paltiel A.D. , Owen W.F. , Lazarus J.M. . Cost-effectiveness of cancer screening in end-stage renal disease. Arch Intern Med 1996; 156: 1345–50.

Evans A.J. , Cohen M.E.L. , Cohen G.F. . Patterns of breast calcification in patients on renal dialysis. Clin Radiol 1992; 45: 343–4.

Wizemann V. , Buddensiek P. , DeBoor J. , Grebe S. , Schütterle G. . Gastrointestinal blood loss in patients undergoing maintenance dialysis. Kidney Int 1983; 24: S218–S20.

Maher A. , Ramanujam L.S. , Gandhi V.C. , Leehey D.J. , Ing T.S. , Schnell T.G. , Daugirdas J.T. . Colon-cancer screening in dialysis patients. Int J Artif Organs 1990; 14: 95–7.

Fairley C.K. , Chen S. , Tabrizi S.N. Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol Dial Transplant 1994; 9: 416–20.

Kabalin J.N. , Hornberger J.C. . Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialyisis. Urology 1991; 37: 308–10.

Sasagawa I. , Nakada T. , Hashimoto T. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients. Urol Int 1992; 48: 181–3.

Monath J.R. , Burkart J.M. , Freedman B.I. , Pittaway D.E. , Russell G.B. , Assimos D.G. . Effects of hemodialysis on prostate-specific antigen. Urology 1993; 42: 398–400.

Morton J.J. , Howe S.F. , Lowell J.A. , Stratta R.J. , Taylor R.J. . Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br J Urol 1995; 75: 498–501.

DeSanto N.G. , Veneroso S. , Capodicasa G. , Crisci A. , Giordano C. . Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50, and α-fetoprotein. Am J Nephrol 1986; 6: 458–63.

Walz G. , Kunzendorf U. , Keller F. , Fitzner R. , Offermann G. . Elevated tumor markers in hemodialysis patients. Am J Nephrol 1988; 8: 187–9.

Cases A. , Filella X. , Molina R. , Ballesta A.M. , Lopez-Pedret J. , Revert L. . Tumor markers in chronic renal failure and hemodialysis patients. Nephron 1991; 57: 183–6.

Zeferos N. , Digenis G.E. , Christophoraki M. Tumor markers in patients undergoing hemodialysis or kidney transplantation. Nephron 1991; 59: 618–20.

Docci D. , Pistocchi E. , Turci F. , Baldrati L. , Urbini S. , Scaioli S. . Serum CA 19–9 and CA 50 antigens in hemodialysis patients. Clin Nephrol 1987; 27: 179–81.

Menzin A.W. , Kobrin S. , Pollak E. , Goodman D.B.P. , Rubin S.C. . The effect of renal function on serum levels of CA 125. Oncology 1995; 58: 375–7.

Bastani B. , Chu N. . Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation. Am J Nephrol 1995; 15: 468–72.

Austin L.A. , Heath H. . Calcitonin: physiology and pathophysiology. N Engl J Med 1981; 304: 269–78.

Myers J.B. , Frost M. , Coates A.S. , Mathews J.D. , Kincaid-Smith P. . Carcinoembryonic antigen in renal allograft recipients and immunosuppressed renal patients. Aust N Z J Med 1977: 7: 16–9.

Brandstetter R.D. , Graziano V.A. , Wade M.J. , Saal S.D. . Carcinoembryonic antigen elevation in renal failure. Ann Intern Med 1979; 91: 867–8.